These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 12975485

  • 1. Interaction of imatinib mesilate with human P-glycoprotein.
    Hamada A, Miyano H, Watanabe H, Saito H.
    J Pharmacol Exp Ther; 2003 Nov; 307(2):824-8. PubMed ID: 12975485
    [Abstract] [Full Text] [Related]

  • 2. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
    Hira A, Watanabe H, Maeda Y, Yokoo K, Sanematsu E, Fujii J, Sasaki J, Hamada A, Saito H.
    Biochem Pharmacol; 2008 Feb 15; 75(4):973-80. PubMed ID: 18054347
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Outward transfer of dopamine precursor L-3,4-dihydroxyphenylalanine (L-dopa) by native and human P-glycoprotein in LLC-PK(1) and LLC-GA5 col300 renal cells.
    Soares-Da-Silva P, Serrão MP.
    J Pharmacol Exp Ther; 2000 May 15; 293(2):697-704. PubMed ID: 10773046
    [Abstract] [Full Text] [Related]

  • 6. Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein.
    Woodahl EL, Yang Z, Bui T, Shen DD, Ho RJ.
    J Pharmacol Exp Ther; 2004 Sep 15; 310(3):1199-207. PubMed ID: 15100388
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
    Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R.
    J Pharmacol Exp Ther; 1992 Nov 15; 263(2):840-5. PubMed ID: 1359120
    [Abstract] [Full Text] [Related]

  • 9. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
    Molnár J, Kars MD, Gündüz U, Engi H, Schumacher U, Van Damme EJ, Peumans WJ, Makovitzky J, Gyémánt N, Molnár P.
    Acta Histochem; 2009 Nov 15; 111(4):329-33. PubMed ID: 19124148
    [Abstract] [Full Text] [Related]

  • 10. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K, Lan LB, Sanglard D, Furuya K, Schuetz JD, Schuetz EG.
    J Pharmacol Exp Ther; 2002 Oct 15; 303(1):323-32. PubMed ID: 12235267
    [Abstract] [Full Text] [Related]

  • 11. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
    Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, Gefroh HA, Devane CL.
    J Pharmacol Exp Ther; 2006 May 15; 317(2):850-7. PubMed ID: 16439618
    [Abstract] [Full Text] [Related]

  • 12. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein.
    Zhang C, Kwan P, Zuo Z, Baum L.
    Life Sci; 2010 Jun 05; 86(23-24):899-905. PubMed ID: 20417647
    [Abstract] [Full Text] [Related]

  • 13. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
    Feng B, Mills JB, Davidson RE, Mireles RJ, Janiszewski JS, Troutman MD, de Morais SM.
    Drug Metab Dispos; 2008 Feb 05; 36(2):268-75. PubMed ID: 17962372
    [Abstract] [Full Text] [Related]

  • 14. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
    Hsiao P, Bui T, Ho RJ, Unadkat JD.
    Drug Metab Dispos; 2008 Mar 05; 36(3):481-4. PubMed ID: 18057117
    [Abstract] [Full Text] [Related]

  • 15. Thalidomide does not interact with P-glycoprotein.
    Zimmermann C, Gutmann H, Drewe J.
    Cancer Chemother Pharmacol; 2006 May 05; 57(5):599-606. PubMed ID: 16136308
    [Abstract] [Full Text] [Related]

  • 16. Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.
    Cho HJ, Choi MK, Lin H, Kim JS, Chung SJ, Shim CK, Kim DD.
    J Pharm Pharmacol; 2011 Mar 05; 63(3):385-91. PubMed ID: 21749386
    [Abstract] [Full Text] [Related]

  • 17. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME, Podila L, Ely D, Almeida I.
    Drug Metab Dispos; 2005 Nov 05; 33(11):1679-87. PubMed ID: 16093365
    [Abstract] [Full Text] [Related]

  • 18. Effect of imatinib mesilate on the disposition kinetics of ciclosporin in rats.
    Kajita T, Higashi Y, Imamura M, Maida C, Fujii Y, Yamamoto I, Miyamoto E.
    J Pharm Pharmacol; 2006 Jul 05; 58(7):997-1000. PubMed ID: 16805961
    [Abstract] [Full Text] [Related]

  • 19. P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers.
    Endter S, Becker U, Daum N, Huwer H, Lehr CM, Gumbleton M, Ehrhardt C.
    Cell Tissue Res; 2007 Apr 05; 328(1):77-84. PubMed ID: 17165089
    [Abstract] [Full Text] [Related]

  • 20. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1.
    Ito T, Yano I, Tanaka K, Inui KI.
    J Pharmacol Exp Ther; 1997 Aug 05; 282(2):955-60. PubMed ID: 9262363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.